{"title": "FDA restricts J&J's COVID-19 vaccine due to blood clot risk", "author": "MATTHEW PERRONE; LAURAN NEERGAARD; The Associated Press", "url": "https://katv.com/news/coronavirus/fda-restricts-jjs-covid-19-vaccine-due-to-blood-clot-risk-covid19-covid-coronavirus-vaccine-clots-johnson-and-johnson-vaccine-risks-danger-cdc-moderna-pfizer", "hostname": "katv.com", "description": "WASHINGTON (AP) \u2014 U. S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. U. S. authorities for months have recommended that Americans get Pfizer or Moderna shots instead of J&J's vaccine. FDA's vaccine chief Dr.", "sitename": "KATV", "date": "2022-05-05", "cleaned_text": "FDA restricts J&J's COVID-19 vaccine due to blood clot risk by MATTHEW PERRONE and LAURAN NEERGAARD | The Associated Press FILE - Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in Denver on Saturday, March 6, 2021. On Thursday, May 5, 2022, U.S. regulators strictly limited who can receive this vaccine due to a rare but serious risk of blood clots. (AP Photo/David Zalubowski, File) "}